IDHC Integrated Diagnostics Holdings Plc

LSE · GB · Healthcare · Diagnostics & Research · idhcorp.com

0.5480USD+4.98%Mkt Cap: 318.57M $P/E: 10.963d ago

Integrated Diagnostics Holdings plc, a consumer healthcare company, provides medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematolo…

Industry Peers

Diagnostics & Research

Screen all

TMO

Thermo Fisher Scientific Inc Common Stock

$242.11BUSDP/E 35.5

DHR

Danaher Corporation Common Stock

$150.48BUSDP/E 38.2

NTRA

Natera, Inc. - Common Stock

Agilent Technologies, Inc. Common Stock

$47.30BUSDP/E 33.1

IQV

IQVIA Holdings, Inc. Common Stock

$42.50BUSDP/E 32.2

WAT

Waters Corporation Common Stock

$41.75BUSDP/E 107.4

ILMN

Illumina, Inc. - Common Stock

$41.23BUSDP/E 50.8

IDXX

IDEXX Laboratories, Inc. - Common Stock

$40.89BUSDP/E 36.4

MTD

Mettler-Toledo International, Inc. Common Stock

$29.78BUSDP/E 34.0

DGX

Quest Diagnostics Incorporated Common Stock

$25.75BUSDP/E 25.0

Labcorp Holdings Inc. Common Stock

$25.02BUSDP/E 25.5

Guardant Health, Inc. - Common Stock

$23.86BUSD

RVTY

Revvity, Inc. Common Stock

$16.91BUSDP/E 72.5

MEDP

Medpace Holdings, Inc. - Common Stock

$16.73BUSDP/E 35.2

ERF

Eurofins Scientific SE

$14.05BUSDP/E 26.2

CRL

Charles River Laboratories International, Inc. Common Stock

$13.85BUSD

ICLR

ICON plc - Ordinary Shares

Qiagen N.V. Common Shares

$9.24BUSDP/E 22.7

Key Statistics

Company

Market Cap318.57M USD

Enterprise Value—

Revenue (TTM)—

Gross Profit3.35B USD

Net Income (TTM)1.26B USD

Revenue/Share—

Last Price0.5480 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees7.1K

CountryGB

SectorHealthcare

IndustryDiagnostics & Research

ISINJE00BLKGSR75

Valuation

P/E (Trailing)10.96

P/E (Forward)0.31

PEG—

EV/EBITDA—

EV/Revenue—

P/S—

P/B0.10

EPS (TTM)0.05

EPS (Forward)1.77

52W Range

0.440027% of range0.8350

52W High0.8350 USD

52W Low0.4400 USD

Profitability

Gross Margin42.69%

Oper. Margin0.00%

EBITDA Margin31.92%

Profit Margin16.07%

ROE37.31%

ROA14.69%

Growth

Revenue Growth42.00%

Earnings Growth25.50%

Cash Flow & Leverage

Operating CF1.90B USD

CapEx (TTM)521.04M USD

FCF Margin—

FCF Yield341.15%

Net Debt—

Net Debt/EBITDA—

Balance Sheet

Debt/Equity0.48

Current Ratio1.67

Quick Ratio1.35

Book Value/Sh5.37 USD

Cash/Share—

Dividends

Fwd Div Rate0.01 USD

Trail. Div Rate0.00 USD

Div. Yield1.55%

5Y Avg Yield5.70%

Payout Ratio48.11%

Ex-Div DateMay 28, 2026

Pay Date—

Splits

Last Split4:1

Split DateDec 24, 2020

Analyst Consensus

Rating—

Target (Mean)0.8065 USD

Upside (mean)+47.2%

Target Range0.7156 USD – 0.8973 USD

0.7156+47.2% to mean0.8973

# Analysts2

Ownership

Shares Out.581.33M

Float124.82M

Insiders58.73%

Institutions45.04%

Technical

SMA 500.5405 (+1.4%)

SMA 2000.5824 (-5.9%)

Beta0.40

S&P 52W Chg14.58%

Avg Vol (30d)65.19K

Avg Vol (10d)59.30K

Technical Indicators

RSI (14)54.3

MACD0.0001

MACD Signal-0.0012

MACD Hist.+0.0013

BB Upper0.5529 USD

BB Middle0.5330 USD

BB Lower0.5131 USD

BB Width7.46%

ATR (14)0.0268 USD

Vol Ratio (20d)0.58x